This compound is a dual incretin receptor agonist that targets both GLP-1 and GIP pathways, making it a subject of significant interest in metabolic and endocrine research. By engaging these hormonal pathways, it has been studied for its effects on glucose regulation, insulin sensitivity, appetite signaling, and energy balance.
Researchers are particularly interested in how GLP-2 influences metabolic processes, including its potential role in supporting weight management and glycemic control through modulation of hormonal responses. Its dual-action mechanism distinguishes it from single-pathway compounds, offering a broader scope for investigation into metabolic function and regulation.
This compound is intended strictly for laboratory research and scientific study by qualified professionals.
For Research Use Only. Not for human consumption. Not for veterinary use. This product is not intended to diagnose, treat, cure, or prevent any disease.